Remote (US) · $340K–$390K
Posted Jun 15, 2026 · 5+ years required
Opens Enveda Therapeutics, Inc.'s own application page in a new tab, this page stays open behind it.
Sr. HR Coordinator
Named on Enveda Therapeutics, Inc.'s FY2026 H-1B filings
Sign in to see their name and work email, plus a short intro note you can edit and send. You reach a person instead of dropping your resume into another online form. Not always the recruiter for this opening.
Create a free accountFiling data last recomputed Aug 9, 2026.
Sponsor score is an evidence index from 0 to 100, built from this employer's past public DOL and USCIS filings. It is not a probability that this role will sponsor you. Read how scores work.
Let’s build the future of medicine - together.
Join Enveda as a Sr. ADME and Quantitative Pharmacology Director and help us transform natural compounds into life-changing medicines. We’re a team driven by curiosity and innovation - are you ready to make a difference?
We're a clinical-stage, AI-enabled biotech discovering medicines from nature four times faster than the industry standard. We recently raised $311M in a Series E, bringing total funding to over $845M, and doubled our valuation to $2B. We now have three oral medicines in the clinic, including our lead drug, ENV-294, in Phase 2 trials for eczema and asthma. Forbes named us one of America's Best Startup Employers, and Newsweek recognized us as a Top 100 Most Loved Workplace. We're still early, and most of the best work is ahead of us.
These milestones reflect the impact of our team and we’re just getting started, but they’re only possible because of the diverse talent, perspectives, and relentless drive of our team, and people like you.
At Enveda, every role drives impact. As the Sr. ADME and Quantitative Pharmacology Director, you’ll provide strategic leadership across DMPK, clinical pharmacology, and modeling & simulation for our expanding portfolio. You will be a key member of the AQP team, reporting to the VP, AQP, and will oversee DMPK and PK/PD activities from candidate nomination through clinical development - making significant contributions to integrated drug development strategy within a diverse R&D organization.